spacer
home > pmps > summer 2007 > pure water for clear results
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Pure Water for Clear Results

An on demand supply of purified water is essential for pharmaceutical laboratories to operate effectively, explains Mark Bosley of Purite

Purified water is used for a wide range of applications in pharmaceutical laboratories, from drug formulations to glassware rinsing. In order for these to be carried out effectively and safely, the water used needs to be suitably processed and treated to eliminate microbial, chemical and endotoxin contaminants. The latest generation of water purification technology is now making this achievable more simply and cost-effectively than was previously possible.

A range of solutions is now available to produce varying levels of water purity for different applications, with the highest levels typically being required in cell culture, media preparation, DNA sequencing and genome research. It is worth noting that water purity for these applications is normally measured in terms of either resistance (expressed as Megohms centimetre or MΩcm) or conductivity (measured in microSiemens per centimetre or μS/cm), as the concentration of ionic contaminants will determine the level of electrical conductivity.

MEASURING QUALITY

In the pharmaceutical industry, water quality is regulated by various national and international bodies, specifying three commonly used grades of water. The United States Pharmacopoeia (USP) specify two grades – purified water (PW) and water for injection (WFI), whereas the European Pharmacopoeia (EP) specify an additional grade – highly purified water (HPW).

These pharmacopoeia outline specific parameters and measuring criteria for the water used for certain applications; however, they do not typically detail the system design considerations or maintenance regimes necessary to achieve these quality levels. This falls within the remit of a number of validating bodies, such as the US Food and Drug Administration (FDA), which aim to ensure compliance with standards by checking that system design, installation, monitoring and maintenance procedures are in place to facilitate consistent and traceable performance to the relevant standards. In addition to these organisations, a number of documents are available, such as the current good manufacturing practice (cGMP) and the ISPE Water and Steam Guide, which also provides assistance for organisations with purified water requirements.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
5
     

There are no comments in regards to this article.

spacer
Mark Bosley has worked for Purite for over 11 years and is currently employed as a Technical Specialist, working within the company’s team of development experts for advanced custom-built and standard plant for the pharmaceutical and related sectors. In total, Mark has over 25 years’ experience in the water treatment industry. This has included work in the development of water purification systems for boiler feed, cooling towers, heating and ventilating equipment and, more recently, in the design of specialised purified water systems for a variety of market sectors, including brewing and distilling, food processing and healthcare. Mark is also a leading contributor and speaker at medical and healthcare conferences, with particular expertise in the design and specification of large ultrafiltration systems, and in writing detailed validation documentation for all types of water purification plant.
spacer
Mark Bosley
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

High Throughput Analytics Herald a Paradigm Shift in the Development of Biopharmaceuticals

Heilbronn/Dortmund August 2019: Biopharmaceuticals have revolutionized therapies of various diseases. In particular with regard to chronical and/or severe clinical conditions like multiple sclerosis, rheumatoid arthritis or cancer they are considered the future of treatment. Also economically biological drugs are on their way up: The global biopharmaceuticals market is anticipated to reach about 400 billion USD by 2025. Which strategic alignment will help best to fill a successful pipeline?
More info >>

White Papers

Inhaler Adherence: Exploring Key Factors

Aptar Pharma

Aptar Pharma recently hosted an expert panel roundtable on “Inhaler Adherence”. This international scientific forum was held in Paris, France on November 29th 2013. The roundtable was organized to explore and exchange views on the issues which may influence inhaler adherence/ compliance with a particular focus on asthma and C.O.P.D. therapies and their corresponding inhaler devices (MDIs, DPIs).
More info >>

 
Industry Events

SMi Presents the 4th Annual: Highly Potent Active Pharmaceutical Ingredients (HPAPI)

11-13 May 2020, Copthorne Tara Hotel, London, UK

SMi is delighted to announce its 4th Annual Highly Potent Active Pharmaceutical Ingredients conference coming to London on the 11th – 12th May 2020. HPAPI 2020 conference focuses on the growing landscape driven by the demand for highly potent drugs in oncology, diabetes and autoimmune disease treatment. This event will address the biggest challenges the industry is facing with regards to determining toxicology limits, assessing hazards, implementing risk procures, translating risk assessment into facility engineering, preventing and dealing with cross-contamination and adhering to GMP regulatory guidelines.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement